Osaka Hirohisa, Yashiro Masakazu, Sawada Tetsuji, Katsuragi Kei, Hirakawa Kosei
Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Clin Cancer Res. 2004 Oct 15;10(20):6912-8. doi: 10.1158/1078-0432.CCR-04-0476.
A sentinel node is defined as the initial lymph node, to which cancer cells metastasize from a primary tumor. Recently, sentinel node navigation surgery has been done using the dye-guided method. However, no study has shown that a lymph node detected by the dye-guided method is the true sentinel node from the viewpoint of micrometastasis. Micrometastases of lymph nodes, in which no metastasis was found by H&E staining, were examined to establish whether a lymph node detected by the dye-guided method is the true sentinel node.
Isosulfan blue was injected endoscopically as the dye-guided method at a submucosal lesion of early gastric cancer. Total 345 lymph nodes, including 150 blue-dyed lymph nodes and 195 nondyed lymph nodes were collected from 57 patients and each was quartered. Two quarters were examined histologically by H&E staining and cytokeratin staining. The other specimens were used for quantitative reverse transcription-PCR of CEA and CK20 mRNAs.
Lymph node disease was not found in any of 345 lymph nodes from the 57 patients by routine H&E staining. By contrast, either CEA or CK20 mRNA expression was detected in 21 of 345 lymph nodes obtained from the 10 (18%) of 57 patients by quantitative reverse transcription-PCR. Eight of the 21 micrometastasis-positive lymph nodes were confirmed to be positive for cytokeratin staining. Although micrometastasis of nondyed lymph nodes was found in three cases, these were included in the 10 cases with micrometastasis of blue-dyed nodes, such that there was no patient who only had micrometastasis in nondyed nodes. Six of 10 cases were micrometastasis-positive in a single node; all six were blue-dyed nodes.
A lymph node detected by the dye-guided method should be a true sentinel node to which cancer cells metastasize initially.
前哨淋巴结被定义为原发肿瘤癌细胞最初转移至的首个淋巴结。近来,已采用染料引导法进行前哨淋巴结导航手术。然而,从微转移的角度来看,尚无研究表明通过染料引导法检测到的淋巴结就是真正的前哨淋巴结。对苏木精-伊红(H&E)染色未发现转移的淋巴结微转移情况进行检测,以确定通过染料引导法检测到的淋巴结是否为真正的前哨淋巴结。
以内镜方式将异硫蓝作为染料引导法注射到早期胃癌的黏膜下病变处。从57例患者中收集了总共345个淋巴结,包括150个被染成蓝色的淋巴结和195个未染色的淋巴结,并将每个淋巴结切成四等份。两份通过H&E染色和细胞角蛋白染色进行组织学检查。其他标本用于癌胚抗原(CEA)和细胞角蛋白20(CK20)mRNA的定量逆转录聚合酶链反应(RT-PCR)。
57例患者的345个淋巴结经常规H&E染色均未发现淋巴结病变。相比之下,通过定量RT-PCR在57例患者中的10例(18%)获取的345个淋巴结中的21个检测到CEA或CK20 mRNA表达。21个微转移阳性淋巴结中的8个经证实细胞角蛋白染色呈阳性。尽管在3例未染色淋巴结中发现了微转移,但这些病例包含在10例蓝色染色淋巴结微转移的病例中,因此没有患者仅在未染色淋巴结中有微转移。10例中有6例在单个淋巴结中微转移呈阳性;所有6个均为蓝色染色淋巴结。
通过染料引导法检测到的淋巴结应是癌细胞最初转移至的真正前哨淋巴结。